US Patent Issued to WUXI BIOLOGICS (SHANGHAI) on July 29 for "Monoclonal antibody against human LAG-3, method for preparing the same, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,493, issued on July 29, was assigned to WUXI BIOLOGICS (SHANGHAI) Co. LTD. (Shanghai).

"Monoclonal antibody against human LAG-3, method for preparing the same, and use thereof" was invented by Yong Zheng (Shanghai), Qiong Wu (Shanghai) and Jing Li (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are novel fully human monoclonal antibodies that bind to human LAG-3. It also provides the methods of hybridoma generation using humanized rats, the nucleic acid molecules encoding the anti-LAG-3 antibodies, expression vectors and host cells used for the expression of anti-LAG-3 antibodies. The invention further provides the methods for vali...